Showing 341 - 360 results of 32,221 for search '(( a ((mean decrease) OR (linear decrease)) ) OR ( a ((largest decrease) OR (greater decrease)) ))', query time: 0.62s Refine Results
  1. 341
  2. 342
  3. 343
  4. 344
  5. 345
  6. 346
  7. 347
  8. 348
  9. 349
  10. 350

    Evaluation index results for the JS-10 phantom. by Masakazu Tsujimoto (22339504)

    Published 2025
    “…At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …”
  11. 351

    NEMA IEC body phantom. by Masakazu Tsujimoto (22339504)

    Published 2025
    “…At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …”
  12. 352

    Relationship between contrast, noise, and CNR. by Masakazu Tsujimoto (22339504)

    Published 2025
    “…At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …”
  13. 353

    JS-10 phantom. by Masakazu Tsujimoto (22339504)

    Published 2025
    “…At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …”
  14. 354

    The raw data used for the analyses in this study. by Masakazu Tsujimoto (22339504)

    Published 2025
    “…At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …”
  15. 355
  16. 356
  17. 357
  18. 358

    Data_Sheet_1_Planning With Patient-Specific Rectal Sub-Region Constraints Decreases Probability of Toxicity in Prostate Cancer Radiotherapy.pdf by Caroline Lafond (6790544)

    Published 2020
    “…</p><p>Conclusion: Compared to a standard prostate planning, applying dose constraints to a patient-specific SRR by using the achievable mean dose model decreased the mean dose by 7.7 Gy to the SRR and may decrease the relative risk of RB by 22%.…”
  19. 359
  20. 360

    FTY720 treatment decreased phosphorylation of AKT, ERK, and c-myc. by Laura L. Stafman (6577184)

    Published 2019
    “…<p>(A) Immunoblotting for the activated form of AKT–phospho-AKT (Ser473)–and total AKT revealed a decrease in phospho-AKT with no accompanying change in total AKT, indicating a decrease in AKT signaling with FTY720 treatment. …”